
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
24 Oct 2025$WGRX Wellgistics Health shares are absolutely on fire, rocketing more than 185% this afternoon. The healthcare distributor lit up the tape after announcing a strategic partnership with DVLT, a move that apparently resonated with investors betting on its blockchain-driven logistics tech. With volume surging to over 700 million shares, this microcap has become one of the most actively traded names on the market today.
$INBX Inhibrx Biosciences exploded 102% following positive Phase 2 trial results in chondrosarcoma, a rare type of bone cancer. The biotech sector has been buzzing ever since the data dropped, and traders are piling in with conviction. The move puts INBX in the spotlight as one of the biggest clinical trial winners of the week, fueled by massive volume more than 25x its average.
$MOFG MidWestOne Financial Group climbed nearly 40% after the regional bank announced a merger and acquisition deal with Nicolet Bankshares. The market cheered the potential for stronger market share and cost synergies, sending the stock to new highs. It’s rare to see a regional bank move like this, but M&A fever has clearly captured investor attention.
$CYH Community Health Systems jumped 26% after delivering a solid Q3 earnings update and tightening its 2025 EBITDA outlook to the $1.50B - $1.55B range. With positive free cash flow and a renewed focus on efficiency, traders see this as a strong rebound story for a company that’s long struggled with debt and operational headwinds.
$VIOT Viomi Technology surged 21% after announcing a $20 million share repurchase program alongside upcoming H1 2025 financial results. The Chinese smart home company drew attention from retail investors eyeing the buyback as a major confidence signal from management. Trading volume spiked nearly 30x its average, hinting at renewed institutional interest.
On the flip side, some big names couldn’t escape the selloff pressure.
$BYND Beyond Meat collapsed nearly 25% after posting disappointing preliminary Q3 results, revealing further sales declines and margin compression. Analysts were quick to slash price targets, citing continued consumer fatigue with plant-based alternatives. Once a darling of the growth crowd, BYND now looks more like a cautionary tale in market overhype.
$DECK Deckers Outdoor slumped more than 15% despite reporting an earnings beat. Investors seemed unimpressed by management’s guidance, and some analysts downgraded the stock amid profit-taking following a strong run. With RSI now oversold, bargain hunters may start watching for a short-term bounce.
$MSAI MultiSensor AI Holdings plunged over 30% after announcing a $14 million private placement, diluting existing shareholders. While the company aims to strengthen its balance sheet, the market viewed the move as a red flag for near-term value erosion.
$COUR Coursera dipped 13% even as Needham reiterated its Buy rating, suggesting the selloff may be more about market rotation than fundamentals. Despite short-term weakness, analysts still see around 18% upside potential based on current forecasts.
$YGMZ MingZhu Logistics continued its slide, dropping another 18%, marking its fifth consecutive down day. With no clear catalyst to reverse sentiment, momentum traders have been steering clear of this one for now.
Yesterday at 02:16
Yesterday at 01:48
Yesterday at 10:34
Yesterday at 06:28
Yesterday at 03:38
October 23, 2025 08:55 PM
October 23, 2025 08:48 PM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Yesterday at 02:16
Yesterday at 01:48
Yesterday at 10:34
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.